Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Current Aging Science|June 19, 2013
The mini-mental Parkinson's (MMP) as a cognitive screening tool in people with Parkinson's diseaseRobert Caslake, Fiona Summers, Douglas McConachie, et al.Pharmacoeconomics|February 13, 2020
Ocrelizumab for Treating Patients with Primary Progressive Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalPeter Auguste, Jill Colquitt, Martin Connock, et al.Parkinsonism & Related Disorders|May 13, 2014
Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE studyRobert Caslake, Kate Taylor, Neil Scott, et al.Parkinsonism & Related Disorders|March 7, 2013
Age-, gender-, and socioeconomic status-specific incidence of Parkinson's disease and parkinsonism in northeast Scotland: the PINE studyRobert Caslake, Kate Taylor, Neil Scott, et al.Parkinsonism & Related Disorders|January 3, 2016
A randomized trial of specialized versus standard neck physiotherapy in cervical dystoniaCarl Counsell, Hazel Sinclair, Jillian Fowlie, et al.Health Technology Assessment (Winchester, England)|March 25, 2022
Pre-hospital and emergency department treatment of convulsive status epilepticus in adults: an evidence synthesisMoira Cruickshank, Mari Imamura, Corinne Booth, et al.Journal of Neurology|January 30, 2022
Management of the first stage of convulsive status epilepticus in adults: a systematic review of current randomised evidenceMoira Cruickshank, Mari Imamura, Carl Counsell, et al.International Journal of Technology Assessment in Health Care|December 13, 2022
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosisXavier Armoiry, Xia Wang-Steverding, Martin Connock, et al.Age and Ageing|March 24, 2012
Developing predictive models of excellent and devastating outcome after strokeJohn M Reid, Dingwei Dai, Christine Christian, et al.BMJ (Clinical Research Ed.)|August 18, 2004
Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patientsNatalie J Ives, Rebecca L Stowe, Joanna Marro, et al.Pageof 4